U.S. legal sector leasing reached record 7.3 million square feet in Q2 2026 as law firms expand footprints. Record legal leasing data signals stronger demand for the company's real estate services.
| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | 1 | — | 1 | 1 | — | 1 | 1 |
| total | individual payouts | |
|---|---|---|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | ‡‡‡‡‡ |
|
| 2025 | ‡‡‡‡‡ |
|
| 2024 | ‡‡‡ |
|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | 0.71 |
—
—
|
| 2020 | 0.62 |
—
—
|
| 2019 | 0.57 |
—
—
|
| 2018 | 0.55 |
—
—
|
| 2017 | 0.46 |
—
—
|
| 2016 | 0.39 |
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 767.70 | 793.30 | 784.20 | 500.50 |
| Receivables | 1,535.10 | 1,414.50 | 1,567.80 | 1,532.50 |
| Inventory | — | — | — | — |
| Other | 311.00 | 301.40 | 301.40 | 343.40 |
| 2,803.20 | 2,690.40 | 2,843.10 | 2,626.60 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 1,157.70 | 1,110.50 | 1,225.00 | 1,154.30 |
| ST’ Debt | 149.70 | 103.20 | 124.90 | 243.30 |
| Other | 217.60 | 196.00 | 191.40 | 151.50 |
| 2,397.20 | 2,329.90 | 2,591.80 | 2,436.50 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 2,535.80 | 2,762.60 | — | — |
—
|
| ’25 | 2,284.60 | 2,483.90 | 2,605.90 | 2,913.80 |
10,288.20
|
| ’24 | 2,184.80 | 2,288.00 | 2,344.20 | 2,629.50 |
9,446.50
|
| ’23 | 2,249.30 | 2,406.00 | 2,286.00 | 2,552.40 |
9,493.70
|
| ’22 | 2,331.00 | 2,612.60 | 2,515.10 | 2,647.00 |
10,105.70
|
| ’21 | 1,923.80 | 2,248.30 | 2,332.90 | 2,883.70 |
9,388.70
|
| ’20 | 1,895.40 | 1,743.60 | 1,931.60 | 2,273.10 |
7,843.70
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (243.50) | 54.00 | — | — |
—
|
| ’25 | (162.00) | 9.60 | 235.50 | 257.30 |
340.40
|
| ’24 | (125.10) | 21.80 | 196.10 | 115.20 |
208.00
|
| ’23 | (221.50) | (16.80) | 188.10 | 202.40 |
152.20
|
| ’22 | (158.20) | (88.10) | 51.70 | 243.70 |
49.10
|
| ’21 | (16.40) | 103.30 | 163.40 | 299.20 |
549.50
|
| ’20 | (249.90) | (50.00) | 77.40 | 184.30 |
(38.20)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (255.70) | 45.50 | — | — |
—
|
| ’25 | (166.60) | 0.30 | 225.00 | 234.30 |
293.00
|
| ’24 | (135.60) | 10.00 | 186.70 | 105.90 |
167.00
|
| ’23 | (231.50) | (27.40) | 173.90 | 186.20 |
101.20
|
| ’22 | (177.10) | (99.70) | 37.80 | 237.40 |
(1.60)
|
| ’21 | (29.30) | 95.30 | 152.50 | 277.20 |
495.70
|
| ’20 | (259.70) | (58.00) | 68.30 | 170.20 |
(79.20)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.05) | 0.22 | — | — |
—
|
| ’25 | 0.01 | 0.25 | 0.22 | (0.10) |
0.38
|
| ’24 | (0.13) | 0.06 | 0.14 | 0.48 |
0.56
|
| ’23 | (0.34) | 0.02 | (0.15) | 0.30 |
(0.16)
|
| ’22 | 0.20 | 0.43 | 0.11 | 0.13 |
0.86
|
| ’21 | (0.08) | 0.23 | 0.30 | 0.64 |
1.10
|
| ’20 | (0.25) | (0.46) | (0.17) | (0.12) |
(1.00)
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 10.04 | 6.24 | 9.24 | 7.64 | — | — | — |
Low Price
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 23.54 | 15.63 | 16.11 | 17.33 | — | — | — |
High Price
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 52,000 | 52,000 | 52,000 | 53,000 | — | — | — |
Employees
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.19 | 0.18 | 0.18 | 0.19 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10,105.70 | 9,493.70 | 9,446.50 | 10,288.20 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.32% | 17.40% | 18.27% | 18.27% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 338.00 | (30.00) | 175.80 | 114.20 | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.34% | (0.32%) | 1.86% | 1.11% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 196.40 | (35.40) | 131.30 | 88.20 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 258.70 | 250.90 | 216.20 | 198.70 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 44.83 | 41.84 | 41.27 | 44.50 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 0.87 | (0.16) | 0.57 | 0.38 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.22 | 0.67 | 0.91 | 1.47 | ‡‡‡‡ | ‡‡‡‡ | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.22) | (0.22) | (0.18) | (0.20) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.01) | 0.45 | 0.73 | 1.27 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.37 | 7.40 | 7.67 | 8.46 | ‡‡‡‡‡ | ‡‡‡‡ | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 225.40 | 226.90 | 228.90 | 231.20 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 14.74 | 0.00 | 22.95 | 42.61 | ‡‡‡‡ | ‡‡‡ | ‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.29 | 0.26 | 0.32 | 0.36 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.74 | 1.45 | 1.71 | 1.91 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.54 | 0.52 | 0.56 | 0.55 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (3,441.64) | 48.46 | 31.40 | 19.48 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 49.10 | 152.20 | 208.00 | 340.40 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (50.70) | (51.00) | (41.00) | (47.40) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.60) | 101.20 | 167.00 | 293.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 376.40 | 406.00 | 360.50 | 251.30 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,261.50 | 3,246.60 | 3,042.80 | 2,749.80 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,617.00 | 2,478.90 | 2,249.50 | 1,965.60 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,662.10 | 1,678.00 | 1,755.40 | 1,955.80 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.48% | (0.45%) | 1.71% | 1.16% | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.82% | 3.09% | 5.29% | 7.21% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.63% | (2.12%) | 7.65% | 4.75% | ‡‡‡‡‡ | — | — |
ROE
|
Cushman & Wakefield (CWK), a powerhouse in global commercial real estate services, is staging a compelling comeback after a decade of SPAC-fueled turbulence, COVID shocks, and hybrid work disruptions—now trading at a stunning discount with analyst targets implying 47% mean upside (32-73% range). Revenue has shown resilient cyclicality, compounding at 5.3% CAGR to $9.45 billion in 2024 despite dips, with productivity soaring 26% above 2016 levels and forecasts accelerating to $11.4 billion by 2027 (+21% cumulative). Stock movements tightly track these fundamentals (r≈0.85), with recent stabilization hinting at oversold gems ready to rebound.
Profitability is flipping the script: net income swung to $131 million in 2024 (+474% YoY), ROE hit 7.7%, and FCF per share climbed 63%, backed by a fortress balance sheet (net debt just 0.24x 2025 revenue). Analysts project EPS rocketing 145% to $1.40 by 2027, compressing forward P/E to ~9x—bargain territory versus peers. Multiples scream value at 0.32x trailing P/S and 0.50x forward EV/Sales, 35% below sector norms, primed for re-rating amid rate cuts and AI data center booms.
This setup screams 30-70% upside potential (70% confidence skewed positive), with historical parallels delivering 55% two-year returns. Tailwinds like leasing surges could catapult shares toward 2022 highs, though watch office risks and macro hiccups—dive into the full analysis for the quantitative edge on this undervalued growth play!
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.